Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

AHT release initial results from IVDD project
Dachshund
Dachschunds are 10-12 times more likely to suffer from IVDD than any other breed.

No link found between chromosome 12 and "herniated" cases vs control

Initial results released from the Animal Health Trusts' Dachshund Intervertebral Disease (IVDD) genetics project have revealed that no correlation has been found between the Chromosome 12 region, previously identified by Danish researchers, and the Dachshund Breed Council's "herniated" cases vs controls.  

Herniation of the intervertebral disc (a "slipped disc") is a significant problem in dogs and a common cause of pain and difficulty walking. Although dogs of any breed can be affected, Dachshunds are 10-12 times more likely to suffer than other breeds, indicating that the disorder probably has a genetic component and mutations in specific gene(s) play a role in the development of the condition.

Working in collaboration with the Dachshund Breed Council, the AHT launched a project last July to investigate the genetics of IVDD in Dachschunds, with the aim of developing a genetics tool that breeders can use to reduce the prevalence of the disease.  

The project was set up to build on the work carried out in 2011 by the University of Copenhagen, which used dogs with calcifications (cases) and dogs without calcifications (controls). The findings from this study gave convincing evidence that genes on chromosome 12 affect the development of intervertebral disc calcification in the Dachshund.

The AHT's project was significantly different to the Copenhagen study, in that it used dogs that have suffered herniations in the lumbar region, and dogs that have never suffered back problems.  

Although they are disappointed with the results, the Dachshund Breed Council said that they always knew there were risks because they were testing a slightly different hypothesis to the Danes.

Cathryn Mellersh, head of molecular genetics at the AHT, said "Moving forward we think the most appropriate next step is to undertake a genome-wide scan that will involve typing a set of cases and controls for around 200,000 markers spanning the dogs’ DNA to try to identify a region of the canine DNA associated with IVDD.

"For this genome scan we need to ensure that we have a robust set of cases, so we will work with a neurologist to review cases to create a tight case definition, as we have previously done for complex conditions in the dog, such as epilepsy."     

Agreeing that further work would be worthwhile, the Dachshund Breed Council added:  "This issue is far too important for the breed's health for us not to explore it further using the technology available." 

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.